1. Home
  2. INGN vs ENLV Comparison

INGN vs ENLV Comparison

Compare INGN & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$5.97

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$2.11

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGN
ENLV
Founded
2001
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
149.0M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
INGN
ENLV
Price
$5.97
$2.11
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$11.25
$20.00
AVG Volume (30 Days)
199.3K
226.1K
Earning Date
05-07-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
N/A
EPS
N/A
N/A
Revenue
$348,668,000.00
N/A
Revenue This Year
$8.03
N/A
Revenue Next Year
$7.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$0.43
52 Week High
$9.13
$7.64

Technical Indicators

Market Signals
Indicator
INGN
ENLV
Relative Strength Index (RSI) 49.39 40.46
Support Level $6.00 $0.77
Resistance Level $6.77 $7.64
Average True Range (ATR) 0.26 0.40
MACD 0.02 -0.36
Stochastic Oscillator 45.68 5.48

Price Performance

Historical Comparison
INGN
ENLV

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: